Skip to main content

Laser-Capture Microdissection and Analysis of Liver Endothelial Cells from Patients with Budd–Chiari Syndrome

  • Protocol
  • First Online:
Laser Capture Microdissection

Part of the book series: Methods in Molecular Biology ((MIMB,volume 755))

Abstract

Myeloproliferative neoplasms (MPN) are clonal hematological malignancies that are frequently ­associated with an acquired somatic mutation in JAK2 (JAK2V617F). Patients with MPN are at a high risk of developing thrombotic events. Endothelial cell (EC) abnormalities are thought to contribute to this prothrombotic state. Budd–Chiari syndrome (BCS) and portal vein thromboses have been reported to be associated with JAK2V617F positive hematopoiesis. We explored whether JAK2V617F was present in ECs within the vessels of polycythemia vera (PV) patients with BCS using laser-capture microdissection followed by nested PCR or real-time RT-PCR. The presence of JAK2V617F in both ECs and hematopoietic cells belonging to BCS patients with PV indicates that ECs from these patients are involved by the malignant process and that in this subpopulation of patients the disease may originate from a cell common to hematopoietic and endothelial cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Tefferi A, Elliott M. (2007) Thrombosis in myeloproliferative disorders: prevalence, prognostic factors, and the role of leukocytes and JAK2V617F. Semin Thromb Hemost 33, 313–320.

    Article  CAS  Google Scholar 

  2. Wolanskyj AP, Schwager SM, McClure RF, Larson DR, Tefferi A. (2006) Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. Mayo Clin Proc 159–66.

    Google Scholar 

  3. Finazzi G, Rambaldi A, Guerini V, Carobbo A, Barbui T. (2007) Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2 V617F mutation status. Haematologica. 92,135–136.

    Article  Google Scholar 

  4. Robertson B, Urquhart C, Ford I, et al (2007). Platelet and coagulation activation markers in myeloproliferative diseases: relationships with JAK2 V6I7 F status, clonality, and antiphospholipid antibodies. J Thromb Haemost. 5, 1679–1685.

    Article  CAS  Google Scholar 

  5. Bellucci S, Michiels JJ. (2006) The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia. Semin Thromb Hemost. 32, 381–398.

    Article  CAS  Google Scholar 

  6. Duda DG, Fukumura D, Jain RK. (2004) Role of eNOS in neovascularization: NO for endothelial progenitor cells. Trends Mol Med. 10, 143–145.

    Article  CAS  Google Scholar 

  7. Kiladjian JJ, Cervantes F, Leebeek FW, et al. (2008) The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood. 111, 4922–4929.

    Article  CAS  Google Scholar 

  8. Patel RK, Lea NC, Heneghan MA, et al. (2006) Prevalence of the Activating JAK2 Tyrosine Kinase Mutation V617F in the Budd-Chiari Syndrome. Gastroenterology. 130, 2031–2038.

    Article  CAS  Google Scholar 

  9. Espina V, Wulfkuhle JD, Calvert V. et al. (2006) Laser-capture microdissection. Nature Protocols. Nat Protoc. 1, 586–603.

    Google Scholar 

  10. Sozer S, Fiel MI, Schiano T, et al. (2009) The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome. Blood. 113, 5246–5249.

    Article  CAS  Google Scholar 

  11. Zengin E, Chalajour F, Gehling UM, et al. (2006) Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development. 133, 1543–1551.

    Article  CAS  Google Scholar 

  12. Ergun S, Tilki D, Hohn HP, Gehling U, Kilic N. (2007) Potential implications of vascular wall resident endothelial progenitor cells. Thromb Haemost. 98, 930–939.

    Google Scholar 

  13. Masuda N, Ohnishi T, Kawamoto S, Monden M, Okubo K. (1999) Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucleic Acids Res. 27, 4436–4443.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ronald Hoffman .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Sozer, S., Hoffman, R. (2011). Laser-Capture Microdissection and Analysis of Liver Endothelial Cells from Patients with Budd–Chiari Syndrome. In: Murray, G. (eds) Laser Capture Microdissection. Methods in Molecular Biology, vol 755. Humana Press. https://doi.org/10.1007/978-1-61779-163-5_34

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-163-5_34

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-61779-162-8

  • Online ISBN: 978-1-61779-163-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics